ARCHIVES

In Brief: ACCC Lobbyists Got What They Wanted In House Cancer Act Bill; VA Group Review Set May 2

This article is from The Cancer Letter archive.

Vol. 04 No. 17 | April 28, 1978

Download PDF Visit The Full Archive

Related Articles

Children With Recurrent Hodgkin’s Respond To Gemcitabine, Vinorelbine

March 27, 2009

In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents

May 8, 1981

In Brief: DCCR Advisory Committee Meeting Rescheduled; Durant To Head Cooperative Group Chairman

June 29, 1979

NCI Searching for Scientists With “Fire in Belly” As Associate Director for Biological Carcinogenesis

June 19, 1987

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

New Treatment Approach To Treating Brain Tumor

April 26, 2002